IP Verse

Eli Lilly And Company opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Eli Lilly And Company

Patent Number:
EP2784084
Title:
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof
Applicant:
GENENTECH, INC.
Opposition Date:
Mar 16, 2020
Patent Number:
EP3045182
Title:
Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using Same
Applicant:
LABRYS BIOLOGICS INC.
Opposition Date:
Dec 7, 2018
Patent Number:
EP2475388
Title:
Use Of Il-33 Antagonists To Treat Fibrotic Disease
Applicant:
MERCK SHARP & DOHME CORP.
Opposition Date:
Aug 8, 2018
Patent Number:
EP2579902
Title:
Method For Production Of F-18 Labeled Amyloid Beta Ligands
Applicant:
PIRAMAL IMAGING SA
Opposition Date:
Apr 12, 2018
Patent Number:
EP1976558
Title:
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Opposition Date:
Dec 14, 2017

Latest patents of Eli Lilly And Company opposed by its competitors

Patent:
EP2247558
Grant Date:
Jul 3, 2024
Title:
Novel Imaging Agents For Detecting Neurological Dysfunction
Oppositions:
1
Patent:
EP3630164
Grant Date:
Aug 23, 2023
Title:
Dulaglutide For The Treatment Of Chronic Kidney Disease
Oppositions:
1
Patent:
EP3810201
Grant Date:
Aug 2, 2023
Title:
Gip/Glp1 Agonist Compositions
Oppositions:
7
Patent:
EP3258919
Grant Date:
Nov 9, 2022
Title:
Nasal Powder Formulation For Treatment Of Hypoglycemia
Oppositions:
1
Patent:
EP3226944
Grant Date:
Aug 10, 2022
Title:
Needle Shield Puller Cap Assembly
Oppositions:
1
Patent:
EP3233108
Grant Date:
Mar 30, 2022
Title:
Rapid-Acting Insulin Compositions
Oppositions:
1
Patent:
EP3372238
Grant Date:
Nov 18, 2020
Title:
Insulin Formulations For Rapid Uptake
Oppositions:
2
Patent:
EP3140008
Grant Date:
Apr 17, 2019
Title:
Rapid-Acting Insulin Compositions
Oppositions:
1
Patent:
EP2403520
Grant Date:
Apr 25, 2018
Title:
Insulin Formulations For Rapid Uptake
Oppositions:
2
Patent:
EP2907522
Grant Date:
Aug 2, 2017
Title:
Method Of Increasing Bone Toughness And Stiffness And Reducing Fractures
Oppositions:
3

Competitors of Eli Lilly And Company

BOHMANN, ARMIN K., DR.

ELKINGTON AND FIFE LLP

GENERICS [UK] LIMITED

Want to track Eli Lilly And Company?

Feel free to send us a message here and we will get back to you